A detailed history of Perpetual LTD transactions in Pfizer Inc stock. As of the latest transaction made, Perpetual LTD holds 94,012 shares of PFE stock, worth $2.34 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
94,012
Previous 94,686 0.71%
Holding current value
$2.34 Million
Previous $2.65 Billion 2.69%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$27.7 - $31.39 $18,669 - $21,156
-674 Reduced 0.71%
94,012 $2.72 Billion
Q2 2024

Jul 30, 2024

BUY
$25.26 - $29.6 $665,575 - $779,930
26,349 Added 38.56%
94,686 $2.65 Billion
Q1 2024

Apr 09, 2024

SELL
$25.89 - $29.73 $3,055 - $3,508
-118 Reduced 0.17%
68,337 $1.9 Billion
Q4 2023

Feb 15, 2024

SELL
$26.13 - $33.94 $1.09 Million - $1.42 Million
-41,777 Reduced 37.9%
68,455 $1.97 Billion
Q3 2023

Oct 10, 2023

BUY
$32.09 - $37.51 $1.67 Million - $1.95 Million
52,074 Added 89.54%
110,232 $3.66 Billion
Q2 2023

Jul 13, 2023

SELL
$36.12 - $41.79 $3.19 Million - $3.69 Million
-88,179 Reduced 60.26%
58,158 $2.13 Billion
Q1 2023

May 08, 2023

BUY
$39.39 - $51.28 $3.19 Million - $4.15 Million
80,914 Added 123.68%
146,337 $5.97 Billion
Q2 2020

Nov 18, 2020

BUY
$30.12 - $36.54 $1.97 Million - $2.39 Million
65,423 New
65,423 $4.51 Million
Q1 2020

Nov 18, 2020

SELL
$27.03 - $38.62 $1.77 Million - $2.53 Million
-65,423 Closed
0 $0
Q3 2019

Oct 10, 2019

BUY
$32.49 - $42.13 $113,715 - $147,455
3,500 Added 5.65%
65,423 $2.35 Million
Q2 2019

Jul 30, 2019

SELL
$36.98 - $41.52 $447,457 - $502,392
-12,100 Reduced 16.35%
61,923 $2.68 Million
Q3 2018

Oct 30, 2018

SELL
$34.47 - $41.81 $420,534 - $510,082
-12,200 Reduced 14.15%
74,023 $3.26 Million
Q2 2018

Jul 23, 2018

BUY
$32.98 - $35.16 $2.84 Million - $3.03 Million
86,223 New
86,223 $3.13 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Perpetual LTD Portfolio

Follow Perpetual LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perpetual LTD, based on Form 13F filings with the SEC.

News

Stay updated on Perpetual LTD with notifications on news.